[NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000517:prevention & control; D005858:Germany; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000517:prevention & control; D010438:Peptic Ulcer Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D010439:Peptic Ulcer Perforation / Q000139:chemically induced* / Q000517:prevention & control; D014456:Ulcer / Q000139:chemically induced* / Q000517:prevention & control
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors